Benefits of Ophdiat®, a telemedical network to screen for diabetic retinopathy: A retrospective study in five reference hospital centres

Diabetes and Metabolism

Volumn 35, Issue 3, 2009, Pages 228-232

  Chabouis, A ^a   Berdugo, M ^b   Meas, T ^c   Erginay, A ^c   Laloi Michelin, M ^c   Jouis, V ^b   Guillausseau, P J ^c   M'Bemba, J ^d   Chaine, G ^e   Slama, G ^d   Cohen, R ^e   Reach, G ^e   Marre, M ^f   Chanson, P ^g   Vicaut, E ^b   Massin, P ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔTEL DIEU   (France)

^e AVICENNE HOSPITAL   (France)

^f BICHAT HOSPITAL   (France)

^g BICÊTRE HOSPITAL   (France)

Author keywords

Diabetic retinopathy; Quality control; Screening; Telemedicine

Indexed keywords

ADULT; ARTICLE; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EYE EXAMINATION; FEMALE; FRANCE; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SCREENING TEST; TELEMETRY; AGED; CLINICAL TRIAL; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; TELEMEDICINE;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FRANCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; TELEMEDICINE; YOUNG ADULT;

EID: 67349120663     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.12.001     Document Type: Article

References (21)

1. Franck R.N. Diabetic retinopathy. N Eng J Med 350 (2004) 48-58
2. Klein R., Klein B.E.K., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984) 520-526
3. Klein R., Klein B.E.K., Moss S.E., Davis M.D., and Demets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 102 (1984) 527-532
4. Sjölie A.K., Stephenson J., Aldington S., Kohner E., Janka H., Stevens L., et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. Ophthalmology 104 (1997) 252-260
5. Delcourt C., Vilatte-Cathelineau B., Vauzelle-Kervroedan F., Cathelineau G., and Papoz L. Visual impairment in type 2 diabetic patients. Acta Ophthalmol Scand 73 (1995) 293-298
6. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991;98:766S-85S.
7. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial-Diabetic Retinopathy Vitrectomy Study Report 3. Ophthalmology 1988;95:1307-20.
8. Agardh E., Agardh C.D., and Hansson-Lunblad C. The five-year incidence of blindness after introducing a screening program for early detection of treatable diabetic retinophathy. Diabet Med 10 (1992) 555-559
9. Kristinsson J.K., Hauksdottir H., Stefansson E., Jonasson F., and Gislason I. Active prevention in diabetic eye disease. Acta Ophthalmol Scand 75 (1997) 249-254
10. Massin P., Angioi-Duprez K., Bacin F., Cathelineau B., Cathelineau G., Chaine G., et al. Recommandations de l'Alfediam pour le dépistage et la surveillance de la rétinopathie diabétique. Diabetes Metab 22 (1996) 203-209
11. Recommandations de l'Anaes. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications ; complications oculaires. Diabetes Metab 1999;2(suppl.):35-8.
12. French recommendations for good practice Afssaps-HAS 2006. Type 2 diabetes treatment. Diabetes Metab 2006;32:643-8.
13. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
14. Weill A., Ricordeau P., Vallier N., Bourrel R., Fender P., and Allemand H. Les modalités de suivi des diabétiques non insulino traités en France métropolitaine durant l'année 1998. Diabetes Metab 23 (2000) 39-48
15. Fagot-Campagna A., Simon D., Varroud-Vial M., Karima Ihaddadène, Nathalie Vallier, Sandra Scaturro, et al. Caractéristiques des personnes diabétiques traitées et adéquation du suivi médical du diabète aux recommandations officielles. Bull Epidemiol Hebd 49-50 (2003) 238-239
16. Scanlon P.H., Malhotra R., Greenwood R.H., Aldington S.J., Foy C., Flatman M., et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthamol 87 (2003) 1258-1263
17. National Health Service Scotland. Diabetic Retinopathy Screening Implementation Group. Diabetic retinopathy screening services in Scotland: recommendations for implementation. Edinburgh: Scottish Executive, 2003 (Available at: http://www.scotland.gov.uk/Publications/2003/07/17638/23077).
18. UK National Screening Committee. Essential Elements in Developing a Diabetic Retinopathy Screening Programme. Workbook 4, August 2007 (Available at: http://www.nscretinopathy.org.uk).
19. ®: a telemedical network to screen for diabetic retinopathy in Île-de-France. Diabetes Metab 34 (2008) 227-234
20. ®: Quality-assurance programme plan and performance of the network. Diabetes Metab 34 (2008) 235-242
21. Fleiss J.L. Statistical methods for rates and proportions. 2nd Edition (1981), John Wile & Sons, Inc, USA